Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Schering-Plough reports top-line results for Saphris in schizophrenia

Nov. 27, 2008

FDA extends review of Somaxon's NDA for insomnia drug Silenor by 3 months

Nov. 27, 2008

FDA accepts for review Labopharm's trazodone NDA for major depressive disorder

Nov. 27, 2008

Sangamo's new zinc finger protein transcription factor neuroprotective in spinal injury model

Nov. 27, 2008

Antiallodynic activity of Adolor's novel potent NGF-TrkA antagonist

Nov. 26, 2008

UWA-0121 extends L-DOPA activity in primate model of Parkinson's disease

Nov. 26, 2008

MK-677 does not meet efficacy endpoints in a phase II Alzheimer's disease study

Nov. 26, 2008

DepoMed enters into exclusive license agreement with Solvay for DM-1796

Nov. 26, 2008

ChemDiv and Avineuro extend collaboration in Alzheimer's disease

Nov. 26, 2008

Neuromed completes enrollment for phase III trial of NMED-1077 in chronic low back pain

Nov. 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...